134 related articles for article (PubMed ID: 3750374)
21. Pharmacokinetics, brain distribution and plasma protein binding of carbamazepine and nine derivatives: new set of data for predictive in silico ADME models.
Fortuna A; Alves G; Soares-da-Silva P; Falcão A
Epilepsy Res; 2013 Nov; 107(1-2):37-50. PubMed ID: 24050973
[TBL] [Abstract][Full Text] [Related]
22. Carbamazepine and the active epoxide metabolite are effectively cleared by hemodialysis followed by continuous venovenous hemodialysis in an acute overdose.
Harder JL; Heung M; Vilay AM; Mueller BA; Segal JH
Hemodial Int; 2011 Jul; 15(3):412-5. PubMed ID: 21676154
[TBL] [Abstract][Full Text] [Related]
23. Cross-reactivity assessment of oxcarbazepine and its metabolites in the EMIT assay of carbamazepine plasma levels.
Kumps A; Mardens Y
Ther Drug Monit; 1986; 8(1):95-7. PubMed ID: 3515642
[TBL] [Abstract][Full Text] [Related]
24. Valproic acid-carbamazepine interaction: is valproic acid a selective inhibitor of epoxide hydrolase?
Svinarov DA; Pippenger CE
Ther Drug Monit; 1995 Jun; 17(3):217-20. PubMed ID: 7624916
[TBL] [Abstract][Full Text] [Related]
25. Steady-state pharmacokinetics of topiramate and carbamazepine in patients with epilepsy during monotherapy and concomitant therapy.
Sachdeo RC; Sachdeo SK; Walker SA; Kramer LD; Nayak RK; Doose DR
Epilepsia; 1996 Aug; 37(8):774-80. PubMed ID: 8764818
[TBL] [Abstract][Full Text] [Related]
26. Dose-dependent metabolism of carbamazepine in humans.
Bernus I; Dickinson RG; Hooper WD; Eadie MJ
Epilepsy Res; 1996 Jul; 24(3):163-72. PubMed ID: 8832192
[TBL] [Abstract][Full Text] [Related]
27. A comprehensive study of the relation between serum concentrations, concentration ratios, and level/dose ratios of carbamazepine and its metabolites with age, weight, dose, and clearances in epileptic children.
Liu H; Delgado MR
Epilepsia; 1994; 35(6):1221-9. PubMed ID: 7988515
[TBL] [Abstract][Full Text] [Related]
28. Dose-dependent pharmacokinetics of carbamazepine in rats: determination of the formation clearance of carbamazepine-10,11-epoxide.
Remmel RP; Sinz MW; Cloyd JC
Pharm Res; 1990 May; 7(5):513-7. PubMed ID: 2367320
[TBL] [Abstract][Full Text] [Related]
29. Relationship of intraindividual dose to plasma concentration of carbamazepine: indication of dose-dependent induction of metabolism.
Tomson T; Svensson JO; Hilton-Brown P
Ther Drug Monit; 1989 Sep; 11(5):533-9. PubMed ID: 2815227
[TBL] [Abstract][Full Text] [Related]
30. Influence of sex, age, weight, and carbamazepine dose on serum concentrations, concentration ratios, and level/dose ratios of carbamazepine and its metabolites.
Liu H; Delgado MR
Ther Drug Monit; 1994 Oct; 16(5):469-76. PubMed ID: 7846744
[TBL] [Abstract][Full Text] [Related]
31. Carbamazepine-danazol drug interaction: its mechanism examined by a stable isotope technique.
Krämer G; Theisohn M; von Unruh GE; Eichelbaum M
Ther Drug Monit; 1986; 8(4):387-92. PubMed ID: 3824425
[TBL] [Abstract][Full Text] [Related]
32. Brain concentrations of carbamazepine and carbamazepine-10,11-epoxide in epileptic patients.
Friis ML; Christiansen J; Hvidberg EF
Eur J Clin Pharmacol; 1978 Nov; 14(1):47-51. PubMed ID: 729606
[TBL] [Abstract][Full Text] [Related]
33. Free concentration of carbamazepine and carbamazepine-10,11-epoxide in children and adults. Influence of age and phenobarbitone co-medication.
Riva R; Contin M; Albani F; Perucca E; Procaccianti G; Baruzzi A
Clin Pharmacokinet; 1985; 10(6):524-31. PubMed ID: 4064451
[TBL] [Abstract][Full Text] [Related]
34. In vitro and in vivo microdialysis calibration for the measurement of carbamazepine and its metabolites in rat brain tissue using the internal reference technique.
Van Belle K; Dzeka T; Sarre S; Ebinger G; Michotte Y
J Neurosci Methods; 1993 Sep; 49(3):167-73. PubMed ID: 8271836
[TBL] [Abstract][Full Text] [Related]
35. Carbamazepine 10,11-epoxide in children.
Rylance GW; Edwards C; Gard PR
Br J Clin Pharmacol; 1984 Dec; 18(6):935-9. PubMed ID: 6529533
[TBL] [Abstract][Full Text] [Related]
36. Clinical pharmacokinetics and pharmacological effects of carbamazepine and carbamazepine-10,11-epoxide. An update.
Bertilsson L; Tomson T
Clin Pharmacokinet; 1986; 11(3):177-98. PubMed ID: 3524954
[TBL] [Abstract][Full Text] [Related]
37. Simultaneous plasma carbamazepine and carbamazepine-epoxide concentrations in pharmacokinetic and bioavailability studies.
Hooper WD; King AR; Patterson M; Dickinson RG; Eadie MJ
Ther Drug Monit; 1985; 7(1):36-40. PubMed ID: 3992620
[TBL] [Abstract][Full Text] [Related]
38. Severe carbamazepine intoxication unresponsive to albumin-enhanced continuous venovenous hemodiafiltration with low dialysate flow.
Chung YK; Chang KY; Park HS; Kim MH; Lee KM; Lim TS; Kim HW
Hemodial Int; 2014 Apr; 18(2):551-5. PubMed ID: 24422855
[TBL] [Abstract][Full Text] [Related]
39. Problem of spurious correlation in the evaluation of steady-state carbamazepine levels using metabolite data.
van Belle G; Friel PN
Ther Drug Monit; 1986; 8(2):177-83. PubMed ID: 3726931
[TBL] [Abstract][Full Text] [Related]
40. Carbamazepine poisoning treated by multiple extracorporeal treatments.
Payette A; Ghannoum M; Madore F; Albert M; Troyanov S; Bouchard J
Clin Nephrol; 2015 Mar; 83(3):184-8. PubMed ID: 25034444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
